
Mayuglim 3D 2mg/500mg/0.2mg Tablet
Marketer
Mayu Health Care
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Mayuglim 3D 2mg/500mg/0.2mg Tablet
Tri-Comb 2/500/0.2mg tablets are classified as antidiabetic agents, a combination medication for adult type 2 diabetes mellitus management. This formulation helps regulate blood glucose. Administer Tri-Comb 2/500/0.2mg tablets with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially causing kidney damage, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Recognizing these symptoms and having readily available glucose (e.g., sugary foods, fruit juice) is vital. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring and potential blood tests (complete blood count, liver function tests) will be recommended by your doctor.
Uses of Mayuglim 3D 2mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Mayuglim 3D 2mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Mayuglim 3D 2mg/500mg/0.2mg Tablet whole; do not break, crush, or chew it. Administer on an empty stomach.
Common Side effects of Mayuglim 3D 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Mayuglim 3D 2mg/500mg/0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Mayuglim 3D 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Mayuglim 3D 2mg/500mg/0.2mg Tablet works:
Each Mayuglim 3D tablet (2mg/500mg/0.2mg) contains a triple combination of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Mayuglim 3D 2mg/500mg/0.2mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Mayuglim 3D 2mg/500mg/0.2mg Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Mayuglim 3D 2mg/500mg/0.2mg Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The use of Mayuglim 3D 2mg/500mg/0.2mg tablets is likely unsafe for individuals with kidney impairment and should be omitted. Seek medical advice before use. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Mayuglim 3D 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate liver disease, initiation should be at a low dose; however, it's contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Mayuglim 3D 2mg/500mg/0.2mg Tablet :
Should you forget a Mayuglim 3D 2mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mayuglim 3D 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
